XML 64 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Note 10 - Noncontrolling Interest - Clyra Medical (Details Textual) - USD ($)
9 Months Ended 12 Months Ended
Dec. 20, 2022
Mar. 02, 2022
Jun. 30, 2020
Sep. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Apr. 08, 2022
Dec. 31, 2020
Stock Issued During Period, Value, Commitment Fee         $ 0      
Preferred Stock, Shares Outstanding, Ending Balance (in shares)         0 0    
Stock Issued During Period, Value, New Issues         $ 3,617,000 $ 4,882,000    
Proceeds from Issuance of Preferred Stock and Preference Stock         $ 225,000 $ 0    
Clyra Medical [Member]                
Common Stock, Shares, Outstanding, Ending Balance (in shares)         91,149      
Stock Issued During Period, Shares, New Issues (in shares)           161    
Stock Issued During Period, Value, New Issues           $ 50,000    
Shares Issued, Price Per Share (in dollars per share) $ 310       $ 310 $ 310    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)         15,833 14,004   11,411
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)         $ 40.24 $ 1.00    
Clyra Medical [Member] | Share-Based Payment Arrangement, Option [Member]                
Share-Based Payment Arrangement, Expense         $ 408,000 $ 564,000    
Clyra Medical [Member] | Employees and Consultants [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)         1,829 2,594    
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)         10 years      
Clyra Medical [Member] | Employees and Consultants [Member] | Options With the Exercise Price of 1 Dollar [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)         1,597      
Clyra Medical [Member] | Employees and Consultants [Member] | The Remaining Options [Member]                
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)         $ 310      
Clyra Medical [Member] | Employees and Consultants [Member] | Share-Based Payment Arrangement, Option [Member]                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount Rate         30.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum         2.32%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate         40.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)         10 years      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum         3.83%      
Clyra Medical [Member] | Vendors and Employees [Member]                
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)           $ 1.00    
Clyra Medical [Member] | Vendors and Employees [Member] | Share-Based Payment Arrangement, Option [Member]                
Share-Based Payment Arrangement, Expense       $ 564,000 $ 408,000      
Clyra Medical [Member] | Warrants Issued in Conjunction With the Sale of Series A Preferred Stock [Member]                
Warrants and Rights Outstanding, Term (Year) 3 years              
Warrants and Rights Outstanding $ 55,000              
Clyra Medical [Member] | Shares Issued for Debt Owed to Biolargo [Member]                
Debt Conversion, Converted Instrument, Amount   $ 633,091            
Debt Conversion, Converted Instrument, Shares Issued (in shares)   2,032            
Clyra Medical [Member] | Series A Preferred Stock [Member]                
Preferred Stock, Shares Outstanding, Ending Balance (in shares)         2,075      
Stock Issued During Period, Shares, New Issues (in shares) 725              
Shares Issued, Price Per Share (in dollars per share) $ 372              
Proceeds from Issuance of Preferred Stock and Preference Stock $ 225,000              
Preferred Stock, Dividend Rate, Percentage 15.00%              
Clyra Medical [Member] | Revolving Credit Facility [Member] | Vernal Bay Capital Group, LLC [Member] | Inventory Line of Credit [Member]                
Debt Instrument, Interest Rate, Stated Percentage     15.00%          
Line of Credit Facility, Maximum Borrowing Capacity     $ 1,000,000          
Proceeds from Lines of Credit, Total     260,000          
Repayments of Lines of Credit     $ 99,000          
Line of Credit Facility, Covenant, Additional Draws, Maximum Percentage of Total Principal Outstanding Allowed     50.00%          
Line of Credit Facility, Covenant, Additional Draws, Minimum Amount Allowed     $ 200,000          
Debt Instrument, Term (Year)     1 year          
Line of Credit Facility, Monthly Percentage of Gross Product Sales Required to be Used as Payment of Debt on First 180 Days     30.00%          
Line of Credit Facility, Monthly Percentage of Gross Product Sales Required to be Used as Payment of Debt after the First 180 Days     60.00%          
Stock Issued During Period, Shares, Commitment Fee (in shares)     322   322      
Stock Issued During Period, Value, Commitment Fee     $ 70,000          
Debt Instrument, Percentage of Principal Payment, Cap         15.00%      
Long-term Line of Credit, Total         $ 161,000 $ 187,000    
Clyra Medical [Member] | Notes Payable, Other Payables [Member]                
Debt Instrument, Face Amount             $ 100,000  
Debt Instrument, Interest Rate, Stated Percentage             8.00%  
Debt Instrument, Convertible, Sale of Stock Amount             $ 5,000,000  
Debt Instrument, Convertible, Conversion Percentage             70.00%  
Clyra Medical Technologies [Member]                
Noncontrolling Interest, Ownership Percentage by Parent         58.00%      
Clyra Medical [Member] | Common Stock [Member]                
Investment Owned, Balance, Shares (in shares)         52,601      
Clyra Medical [Member] | Preferred Stock, Series A [Member]                
Investment Owned, Balance, Shares (in shares)         1,349